| |
| |
|
| Insider
Information: |
Greenstreet Yvonne |
| Relationship: |
Chief Executive Office... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
86,188 |
|
|
Indirect Shares
|
407 |
|
|
| Direct
Value |
$11,189,805 |
|
|
|
Indirect Value
|
$61,034 |
|
|
| Total
Shares |
86,595 |
|
|
| Total
Value |
$11,250,839 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
4
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
4
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-4.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -36.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Moelis & Co |
MC |
Director |
2018-11-14 |
1,059 |
2015-02-19 |
0 |
Premium* |
|
|
Pacira Pharmaceuticals, Inc. |
PCRX |
Director |
2022-06-08 |
13,247 |
2015-06-03 |
0 |
Premium* |
|
|
Alnylam Pharmaceuticals Inc |
ALNY |
Chief Executive Office... |
2024-03-01 |
71,882 |
2024-03-01 |
407 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
23,754 |
71,882 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2024-02-28 |
4 |
S |
$154.54 |
$455,357 |
D/D |
(2,932) |
48,128 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2024-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,921 |
51,060 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2024-02-16 |
4 |
S |
$147.50 |
$1,040,885 |
D/D |
(7,030) |
45,139 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2024-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
16,953 |
52,169 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2023-08-04 |
4 |
S |
$184.70 |
$753,986 |
D/D |
(4,057) |
35,216 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2023-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
8,941 |
39,273 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2023-04-27 |
4 |
S |
$193.18 |
$1,481,811 |
D/D |
(7,615) |
30,332 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2023-04-26 |
4 |
A |
$0.00 |
$0 |
D/D |
16,952 |
37,947 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2022-08-04 |
4 |
D |
$189.76 |
$1,150,439 |
D/D |
(6,002) |
20,995 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2022-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
13,095 |
26,997 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2022-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
1,160 |
13,247 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President & COO |
• – – |
2021-12-22 |
4 |
D |
$186.55 |
$479,699 |
D/D |
(2,538) |
13,902 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President & COO |
• – – |
2021-12-21 |
4 |
A |
$0.00 |
$0 |
D/D |
5,417 |
16,440 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President & COO |
• – – |
2021-08-06 |
4 |
AS |
$199.00 |
$10,559,736 |
D/D |
(53,064) |
11,023 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President & COO |
• – – |
2021-08-06 |
4 |
OE |
$77.10 |
$4,091,234 |
D/D |
53,064 |
64,087 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2021-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,066 |
12,087 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President & COO |
• – – |
2021-04-20 |
4 |
D |
$131.75 |
$309,977 |
D/D |
(2,351) |
11,023 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President & COO |
• – – |
2021-04-19 |
4 |
A |
$0.00 |
$0 |
D/D |
5,083 |
13,374 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President & COO |
• – – |
2021-02-12 |
4 |
D |
$155.84 |
$303,403 |
D/D |
(1,945) |
8,291 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President & COO |
• – – |
2021-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
5,416 |
10,236 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President & COO |
• – – |
2021-01-12 |
4 |
AS |
$161.00 |
$503,125 |
D/D |
(3,125) |
4,820 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President & COO |
• – – |
2021-01-12 |
4 |
OE |
$42.22 |
$131,938 |
D/D |
3,125 |
7,945 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Chief Operating Officer |
• – – |
2020-07-10 |
4 |
OE |
$77.10 |
$3,595,867 |
D/D |
46,639 |
51,459 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Chief Operating Officer |
• – – |
2020-07-10 |
4 |
AS |
$161.00 |
$7,508,879 |
D/D |
(46,639) |
4,820 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
